We are live on ! Find out more
SC

Sophrosyne Capital Portfolio holdings

AUM $11.5M Turnover 56.25%
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
+10.95%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$114M
AUM Growth
+$7K
Cap. Flow
-$8.9M
Cap. Flow %
-7.79%
Top 10 Hldgs %
52.99%
Holding
94
New
29
Increased
16
Reduced
28
Closed
16
Avg Time Held
0.4 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.5 years

Top Buys

Rank Stock Value
1
SYT
Syngenta Ag
SYT
+$5.86M
2
BFYT
Benefytt Technologies, Inc. Class A Common Stock
BFYT
+$5.08M
3
SHOR
ShoreTel, Inc.
SHOR
+$2.1M
4
SANW icon
S&W Seed Co
SANW
+$1.65M
5
DRTX
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
+$1.38M

Top Sells

Rank Stock Value
1
CALX icon
Calix
CALX
+$6.16M
2
DRRX icon
DURECT Corp
DRRX
+$3.14M
3
LSAK icon
Lesaka Technologies
LSAK
+$3.03M
4
ARAY icon
Accuray
ARAY
+$2.56M
5
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
+$2.36M

Sector Composition

Rank Sector Weight
1 Healthcare 46.71%
2 Technology 20.22%
3 Communication Services 8.22%
4 Materials 7.79%
5 Financials 5.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BEAT icon
1
DELISTED
BioTelemetry, Inc.
BEAT
$11.1M 9.71%
1,098,174
-133,544
-11% -$1.23M
2013 Q2
3 quarters
ZLTQ
2
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$7.61M 6.66%
388,004
-120,900
-24% -$2.36M
2013 Q2
3 quarters
MSTR icon
3
Strategy Inc
MSTR
$64.1B
$6.54M 5.73%
566,630
-30,000
-5% -$375K
2013 Q2
3 quarters
MEET
4
DELISTED
The Meet Group, Inc. Common Stock
MEET
$6.29M 5.51%
1,930,135
-280,752
-13% -$751K
2013 Q2
3 quarters
SYT
5
DELISTED
Syngenta Ag
SYT
$6.05M 5.3%
80,050
+78,700
+5,830% +$5.86M
2013 Q3
2 quarters
FLNA icon
6
Filana Therapeutics
FLNA
$36.8M
$5.17M 4.53%
134,245
-46,472
-26% -$1.64M
2013 Q3
2 quarters
ARCT icon
7
Arcturus Therapeutics
ARCT
$320M
$4.96M 4.34%
39,037
-6,731
-15% -$998K
2013 Q3
2 quarters
BFYT
8
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$4.65M 4.07%
+449,845
New +$5.08M
2014 Q1
0 quarters
BDSI
9
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$4.37M 3.83%
517,662
-177,300
-26% -$1.43M
2013 Q2
3 quarters
LSAK icon
10
Lesaka Technologies
LSAK
$382M
$3.8M 3.33%
381,490
-324,976
-46% -$3.03M
2013 Q2
3 quarters
PCYO icon
11
Pure Cycle
PCYO
$268M
$3.73M 3.26%
616,000
+43,000
+8% +$270K
2013 Q2
3 quarters
TLPH icon
12
Talphera
TLPH
$55.5M
$2.99M 2.62%
12,449
-4,020
-24% -$953K
2013 Q2
3 quarters
PKT
13
DELISTED
PROCERA NETWORKS INC NEW COM STK (DE)
PKT
$2.95M 2.58%
283,690
+31,600
+13% +$373K
2013 Q2
3 quarters
UI icon
14
Ubiquiti
UI
$37.4B
$2.88M 2.52%
63,363
+20,900
+49% +$979K
2013 Q2
3 quarters
ARAY icon
15
Accuray
ARAY
$20.8M
$2.48M 2.17%
258,300
-271,200
-51% -$2.56M
2013 Q2
3 quarters
SANW icon
16
DELISTED
S&W Seed Co
SANW
$2.34M 2.05%
16,624
+12,883
+344% +$1.65M
2013 Q2
3 quarters
SHOR
17
DELISTED
ShoreTel, Inc.
SHOR
$2.1M 1.83%
+243,828
New +$2.1M
2014 Q1
0 quarters
AXGN icon
18
Axogen
AXGN
$2.09B
$1.68M 1.47%
550,607
-81,000
-13% -$323K
2013 Q3
2 quarters
ENVI
19
DELISTED
ENVIVIO INC COM STK (DE)
ENVI
$1.67M 1.47%
542,622
+76,600
+16% +$272K
2013 Q2
3 quarters
P icon
20
DELISTED
Pandora Media Inc
P
$1.65M 1.44%
54,400
-20,800
-28% -$720K
2013 Q2
3 quarters
NES
21
DELISTED
NUVERRA ENVIRONMENTAL INC NEW COM STK (DE)
NES
$1.57M 1.38%
+77,400
New +$1.24M
2014 Q1
0 quarters
CUTR icon
22
DELISTED
Cutera, Inc.
CUTR
$1.56M 1.37%
139,689
-14,400
-9% -$147K
2013 Q2
3 quarters
CSII
23
DELISTED
Cardiovascular Systems, Inc.
CSII
$1.48M 1.3%
46,641
-10,300
-18% -$340K
2013 Q2
3 quarters
ENT
24
DELISTED
Global Eagle Entertainment Inc.
ENT
$1.45M 1.27%
3,672
-200
-5% -$82.2K
2013 Q3
2 quarters
DRTX
25
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
$1.42M 1.25%
+105,500
New +$1.38M
2014 Q1
0 quarters
1
2 3 4

Similar funds

SFM
Socratic Fund Management Short Hills, New Jersey $12M AUM 39.3% 1-Year Est. Return
IACGFA
IDG-Accel China Growth Fund Associates Central, Hong Kong $13.2M AUM 31.6% 1-Year Est. Return
LS
Lupo Securities Chicago, Illinois $13.3M AUM 1.59% 1-Year Est. Return
NGPI
N.G. Partners II Palo Alto, California $9.65M AUM 70.44% 1-Year Est. Return
AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
GRP
Geologic Resource Partners Boston, Massachusetts $9.22M AUM 48.14% 1-Year Est. Return
NVPV
Norwest Venture Partners VIII Palo Alto, California $9.22M AUM
AC
Amiya Capital London, United Kingdom $14.3M AUM 4.61% 1-Year Est. Return

Sophrosyne Capital's Q1 2014 Portfolio in Review

As of Q1 2014, Sophrosyne Capital held 94 positions worth $114M, up 0.01% from $114M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Sophrosyne Capital withdrew a net $8.9M in Q1 2014, closing 16 positions and reducing 28 holdings. Its most notable exit was Calix, an estimated $6.16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 55% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Sophrosyne Capital opened a new position in Benefytt Technologies, Inc. Class A Common Stock worth $4.65M.

  • Sophrosyne Capital's largest Q1 2014 buy was Benefytt Technologies, Inc. Class A Common Stock: 449,845 shares worth $4.65M.
  • Sophrosyne Capital added most to Syngenta Ag in Q1 2014, an estimated $5.86M increase.
  • Sophrosyne Capital's biggest Q1 2014 reduction was Lesaka Technologies, cutting an estimated $3.03M.
  • Sophrosyne Capital fully exited Calix in Q1 2014, selling an estimated $6.16M.
  • Sophrosyne Capital's ten largest holdings make up 53% of its $114M portfolio in Q1 2014.
  • Sophrosyne Capital opened 29 new positions and closed 16 in Q1 2014.
  • Sophrosyne Capital's portfolio value rose 0.01% quarter-over-quarter to $114M.

Based on Sophrosyne Capital's 13F filing for Q1 2014, filed 14 May 2014.